Physician profile
Jared Harris
NPI 1205121365
$514.64
in general payments reported to CMS, 2019-2025
10 companies · $78.48 in 2025
The $78.48 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $41.85 · 2021: $31.87 · 2023: $289 · 2024: $73.93 · 2025: $78.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $440.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $141.79 | 2023 | |
| Ortho Organizers, INC. | $59.58 | 2023 | Reveal Aligners |
| Envista Holdings Corporation | $57.67 | 2024-2025 | Endodontics |
| Kerr Corporation | $43.57 | 2023 | Harmonize, Optibond Xtr |
| Nobel Biocare USA | $43.57 | 2023 | Nobelactive |
| Biohorizons Implant Systems INC. | $41.93 | 2024 | Biohorizons |
| Dentsply Sirona INC | $40.70 | 2020-2025 | Q-Mix |
| 3m Company | $32.77 | 2020-2021 | |
| Philips North America LLC | $28.54 | 2020-2025 | Power Toothbrush Undivided |
| Voco America INC. | $24.52 | 2024-2025 | X-Tra Fil, X-Tra Base, Rebilda Dc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.